Related Experiment Video
Updated: Jun 27, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
Degradation of BRCA2 in alkyltransferase-mediated DNA repair and its clinical implications
Subha Philip1, Srividya Swaminathan, Sergey G Kuznetsov
1Mouse Cancer Genetics Program, Center for Cancer Research, and Pathology Histotechnology Laboratory, Science Applications International Corporation-Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland 21702, USA.
Abstract:
Germ-line mutations in BRCA2 have been linked to early-onset familial breast cancer. BRCA2 is known to play a key role in repairing double-strand breaks. Here, we describe the involvement of BRCA2 in O6-alkylguanine DNA alkyltransferase (AGT)-mediated repair of O6-methylguanine adducts. We show that BRCA2 physically associates and undergoes repair-mediated degradation with AGT. In contrast, BRCA2 with a 29-amino-acid deletion in an evolutionarily conserved domain does not bind to alkylated AGT; the two proteins are not degraded; and mouse embryonic fibroblasts are specifically sensitive to alkylating agents that result in O6-methylguanine adducts. We show that O6-benzylguanine (O6BG), a nontoxic inhibitor of AGT, can also induce BRCA2 degradation. BRCA2 is a viable target for cancer therapy because BRCA2-deficient cells are hypersensitive to chemotherapeutic DNA-damaging agents. We show a marked effect of O6BG pretreatment on cell sensitivity to cisplatin. We also show the efficacy of this approach on a wide range of human tumor cell lines, which suggests that chemosensitization of tumors by targeted degradation of BRCA2 may be an important consideration when devising cancer therapeutics.
Insights
BRCA2 protein aids in DNA repair by interacting with AGT. Inhibiting AGT with O6-benzylguanine degrades BRCA2, making cancer cells more sensitive to chemotherapy.
Area of Science:
- Molecular Biology
- Cancer Research
- DNA Repair Mechanisms
Background:
- Germ-line mutations in BRCA2 are associated with familial breast cancer.
- BRCA2 is crucial for repairing DNA double-strand breaks.
- The DNA repair protein O6-alkylguanine DNA alkyltransferase (AGT) repairs O6-methylguanine adducts.
Purpose of the Study:
- To investigate the role of BRCA2 in AGT-mediated DNA repair.
- To explore the interaction between BRCA2 and AGT.
- To assess the therapeutic potential of targeting this interaction.
Main Methods:
- Studied the physical association and degradation of BRCA2 and AGT.
- Utilized BRCA2 mutants with a 29-amino-acid deletion.
- Assessed sensitivity of mouse embryonic fibroblasts to alkylating agents.
- Investigated the effect of O6-benzylguanine (O6BG) on BRCA2 degradation and cell sensitivity to cisplatin.
Main Results:
- BRCA2 physically associates with AGT and undergoes degradation during repair.
- A specific BRCA2 deletion mutant failed to bind AGT, leading to no degradation and increased sensitivity to alkylating agents.
- O6BG, an AGT inhibitor, induced BRCA2 degradation.
- O6BG pretreatment significantly increased cancer cell sensitivity to cisplatin and other chemotherapeutic agents across various human tumor cell lines.
Conclusions:
- BRCA2 is involved in AGT-mediated repair of O6-methylguanine DNA adducts.
- Targeted degradation of BRCA2, induced by AGT inhibition, enhances cancer cell sensitivity to DNA-damaging chemotherapeutic agents.
- Targeting BRCA2 degradation represents a promising strategy for cancer therapy and chemosensitization.
More Related Videos
08:53Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
Related Concept Videos
Base Excision Repair
The first step of...
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Fixing Double-strand Breaks